Metagenomi Presents In Vivo Preclinical Gene Editing Data Using a Small, Hypoimmune CRISPR-associated Type V Gene Editing System at The Liver Meeting of AASLD

EMERYVILLE, Calif.--(BUSINESS WIRE)--Metagenomi announced that it presented preclinical in vivo data on a novel, small CRISPR-associated Type V gene editing system at The Liver Meeting.

Click to view original post